Research
Micronutrients & recovery
Tocotrienols show promise in managing diabetes and hyperlipidemia by reducing blood glucose, improving insulin sensitivity, and lowering lipid levels in animal models.
While animal studies show tocotrienols can improve blood sugar control and lipid profiles, human evidence is not yet robust enough to recommend them as a primary treatment for diabetes. Consult a doctor before using them for metabolic management.
ModerateSupportsMEDIUM confidence
The TRF at a dose of 1 g/kg bodyweight significantly reduced streptozotocin induced diabetes in Sprague–Dawley rats. It also effectively prevented increase in serum advanced glycosylation end-products (AGE) and malondialdehyde (MDA), and caused decrease in blood glucose and glycatedhemoglobin in diabetic rats.
Why this rating
Based on multiple animal studies, but human clinical data is limited or not explicitly detailed in this review for diabetes.
Source
Pharmacological potential of tocotrienols: a review
Haseeb Ahsan et al. · Nutrition & Metabolism · 2014
narrative_reviewCited 323×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →